• FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • Hrv
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations

News and Educations

  • Homepage
  • News and Educations
  • News

Direct healthcare professional communication with updated information on the risk of diabetic ketoacidosis during treatment with SGLT2 inhibitors (Invokana*, Vokanamet*, Forxiga, Xigduo, Jardiance, Synjardy*)

14.03.2016

more

HALMED and IMROH started formal cooperation in the field of monitoring of drug overdoses

10.03.2016

more

CMDh News – February 2016

07.03.2016

more

Additional guideline concerning the submission of conventional dossiers on medicinal products

02.03.2016

more

CHMP News – February 2016

29.02.2016

more

Beginning of a review of medicines containing dienogest 2 mg and ethinylestradiol 0.03 mg when used for acne

29.02.2016

more

EMA confirms recommendations to minimise risk of brain infection PML with Tysabri

29.02.2016

more

EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes

29.02.2016

more

Measures for additional protection of patients from falsified medicinal products based on the Commission Delegated Regulation (EU) 2016/161 and plans for introduction of new safety features

19.02.2016

more

Notice of unavailability of HALMED's phone numbers

18.02.2016

more

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • »

For Patients and Public

For Health Care Professionals

For Industry Representatives

  • News
    • Archive 2025
    • Archive 2024
    • Archive 2023
    • Archive 2022
    • Archive 2021
    • Archive 2020
    • Archive 2019
    • Archive 2018
    • Archive 2017
    • Archive 2016
    • Archive 2015
    • Archive 2014
    • Archive 2013
    • Archive 2012
    • Archive 2011
    • Archive 2010
    • Archive 2009
  • Press releases
  • HR Presidency of the EU Council 2020
  • Professional and Scientific Events
  • Public Educational Campaigns
  • Publications and Reports
  • Frequently Asked Questions (FAQ)
  • Newsletter and RSS
  • Enquiries
  • Useful Links
  • Homepage
  • FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations
  • HALMED for:
  • Patients and Public
  • Health Care Professionals
  • Industry Representatives

Copyright © 2007-2025. Agency for Medicinal Products and Medical Devices of Croatia.
All rights reserved.